Replies to post #349336 on NorthWest Biotherapeutics Inc (NWBO)

[Dan88]

welcome onboard again my friend, agree on all you said except that I do think investors can have a sigh of relief we have not had negative news yet wrt the trial since data was locked on 5 Otc.

All the best and good luck!

[learningcurve2020]

Most likely they don’t need to report failed trial results because they can always claim they’re trying to change endpoints for a positive outcome. This has been going on for years, IMO, with dl in limbo. Why they refuse to PR the EU endpoint changes is the real question?? It is material but only if it leads to commercialization. Approval just for compassionate use is probably not a material event??

[HappyLibrarian]

NWBO management has proven uncanny at wriggling their way out of disclosure and reporting requirements and anything else that constrains their actions.

In light of this ability, it is a bad idea to put much store in any 4 day window for reporting bad news, especially when that rule is subject to so many 'exclusions and limitations' and there is an honest debate between shareholders here as to whether the 4 day rule is really even a thing.

[biosectinvestor]

I could not agree more with your post. Very nicely enunciated.